EAGAN, Minn.--(BUSINESS WIRE)--Biothera presented data demonstrating the well characterized nature of Imprime PGG®, the company’s developmental cancer drug, at the IBC Life Science 12th annual Well Characterized Biologics Conference last week in Reston, VA.
